These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29616133)

  • 21. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
    Sturgis EM; Zhao C; Zheng R; Wei Q
    Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
    Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
    McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
    J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome.
    Kariola R; Raevaara TE; Lönnqvist KE; Nyström-Lahti M
    Hum Mol Genet; 2002 May; 11(11):1303-10. PubMed ID: 12019211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing how reduced expression levels of the mismatch repair genes MLH1, MSH2, and MSH6 affect repair efficiency.
    Kansikas M; Kasela M; Kantelinen J; Nyström M
    Hum Mutat; 2014 Sep; 35(9):1123-7. PubMed ID: 24924810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
    Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
    Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic DNA mismatch repair.
    Kolodner RD; Marsischky GT
    Curr Opin Genet Dev; 1999 Feb; 9(1):89-96. PubMed ID: 10072354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
    Zhao C; Li S; Zhao M; Zhu H; Zhu X
    Arch Gynecol Obstet; 2018 Jan; 297(1):153-159. PubMed ID: 29063235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients.
    Nogueira GAS; Costa EFD; Lopes-Aguiar L; Lima TRP; Visacri MB; Pincinato EC; Lourenço GJ; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
    Oncotarget; 2018 Jul; 9(51):29538-29547. PubMed ID: 30038702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results.
    Olkinuora A; Gylling A; Almusa H; Eldfors S; Lepistö A; Mecklin JP; Nieminen TT; Peltomäki P
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
    de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H
    Nat Genet; 1999 Nov; 23(3):359-62. PubMed ID: 10545954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Base Excision Repair Gene Polymorphisms and Wilms Tumor Susceptibility.
    Zhu J; Jia W; Wu C; Fu W; Xia H; Liu G; He J
    EBioMedicine; 2018 Jul; 33():88-93. PubMed ID: 29937070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-associated repeat instability and mismatch repair.
    Schmidt MHM; Pearson CE
    DNA Repair (Amst); 2016 Feb; 38():117-126. PubMed ID: 26774442
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Villahermosa D; Christensen O; Knapp K; Fleck O
    G3 (Bethesda); 2017 May; 7(5):1463-1473. PubMed ID: 28341698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
    Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P
    Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
    Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
    Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.